Losartan Potassium Tablet
Product Images NDC 29300-144

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 29300-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 01

Chemical structure of Losartan Potassium, showing its molecular arrangement with atoms and bonds including the potassium ion (K+).*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 02

A line graph comparing the percentage of patients reaching a primary endpoint over a 66-month study period for Atenolol versus Losartan Potassium. The chart shows adjusted risk reduction of 13% for Losartan Potassium with a p-value of 0.021, indicating statistical significance. The x-axis represents study months, and the y-axis shows the percentage of patients with the primary endpoint.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 03

A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over time in months between two treatments: atenolol (dotted line) and losartan potassium (solid line). The graph shows a lower incidence of strokes for losartan potassium, with an adjusted risk reduction of 25% and a p-value of 0.001 indicated.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 04

A forest plot chart comparing the rates and hazard ratios of events between Losartan Potassium and Atenolol. It displays data for overall results and subgroups by age, gender, race, ISH, diabetes status, and history of cardiovascular disease. The horizontal axis indicates hazard ratios favoring either Losartan Potassium or Atenolol, with symbols proportional to sample sizes.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 05

A line graph showing the percentage of patients with an event over 48 months, comparing Losartan Potassium and placebo. The graph indicates a risk reduction of 16.1% with Losartan Potassium at a p-value of 0.022, depicting effectiveness over the study period.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 06

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 07

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 08

Losartan Potassium Tablets USP 25 mg oral tablets label by Unichem Pharmaceuticals (USA), Inc. The label indicates each tablet contains 25 mg of losartan potassium. The package size is 30 tablets. It includes storage instructions, a barcode, and manufacturer information for Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 09

Losartan Potassium Tablets, USP 50 mg oral tablets packaging label from Unichem Pharmaceuticals (USA), Inc. The label includes the National Drug Code (NDC) 29300-145-13, dosage details of 50 mg Losartan Potassium per tablet, and states a 30 tablet count. It also provides storage instructions and manufacturer addresses in India and the USA.*

FDA Label Image

F205834f 7a27 4968 9605 90a2c53ce7e9 10

Losartan Potassium Tablets, USP 100 mg oral tablets packaging label. The label indicates 30 tablets per container, manufactured by Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc. The label includes storage instructions and a barcode, with a clear statement to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.